Image Scan Holdings Plc · LSE:IGE

Image Scan — Shareholder Meeting (February 2012)

14 slides from Image Scan's shareholder meeting presentation, Feb 29, 2012

  1. Slide 1: Annual General Meeting

    ANNUAL GENERAL MEEETING 29 February 2012

  2. Slide 2: Highlights in the year to September 2011

    Highlights in the year to September 2011 • Threefold increase in order intake to £4.3million across all products / sectors • Revenue up 48% to £2.2million • Reduced overheads for fourth consecutive year • Break-even in H2 • Significant nuclear contract of £0.9million • Significant contract win for t

  3. Slide 3: Security Overview

    Security Overview • Security sales up 11% to £1,351,000 (2010: £1,218,000) • Fourth consecutive year with revenue greater than £1.1million • Strong FlatScan sales across all territories • Axis-64 sales to the Middle East and the UK • First tranche of SVXi contract taken to revenue • Sales of complem

  4. Slide 4: Industrial Overview

    Industrial Overview • Threefold increase in industrial revenue to £823,000 (FY:£253,000) • Equates to 38% of 2011 revenue compared to 16% in 2010 • Includes contribution from nuclear, industrial inspection, software upgrades, spares and support contracts • Margins at 39%

  5. Slide 5: Income Statement

    Income Statement 2008 2009 2010 2011 Revenue (£’000) 2,005 1,444 1,472 2,173 Gross Margin (%) 45% 48% 55% 41% Overheads (£’000) 1,360 1,283 1,218 1,169 Profit/(Loss) (£’000) (331) (537) (382) (237) EPS (pence) (0.6) (1.0) (0.6) (0.4)

  6. Slide 6: Sales Mix by Sector

    Sales Mix by Sector 1400 1200 1000 800 Security 600 Industrial 400 200 0 2005 2006 2007 2008 2009 2010 2011

  7. Slide 7: Balance Sheet

    Balance Sheet £’000 2008 2009 2010 2011 Tangible Assets 140 73 49 44 (£’000) Inventories (‘000) 154 233 273 315 Receivables (‘000) 199 246 348 596 Net Cash (£’000) 1,535 850 348 945 Current Liabilities (417) (323) (204) (1,029) (£’000) Net Assets (£’000) 1,611 1,079 814 871

  8. Slide 8: Balance Sheet – in summary

    Balance Sheet – in summary • Year-end net cash at £945,000 (FY10: £348,000) • Current liabilities include £520,000 of advance payments on contracts deliverable in first half of 2012 EOD vehicle inspection • Placing of 15,000,000 shares with proceeds of £300,000 by a Hong Kong based investor • Post y

  9. Slide 9: Commercial Strategy

    Commercial Strategy The commercial strategy is to:  Increase direct customer engagement  Improve end user feedback to drive product development  Extend sales reach through: FlatScan-TPXi and 15 Increased activity in territory Offering a wider product range Additional sales through existing and

  10. Slide 10: Product Development

    Product Development Investment in product development to support strategy during the year and ongoing: Introduction of larger and smaller size AXIS baggage screening systems FlatScan range extended to include smaller panel size SVXi contract enabling incremental development Nuclear Waste ThreatS

  11. Slide 11: 2012 Order Book

    2012 Order Book • FY12 brought forward order book of £2.3million and new orders in the year to date of £0.5million are mostly deliverable in H1. These include:  £0.7m nuclear sector contract  £1.3m SVXi vehicle systems  £0.1m AXIS baggage systems Nuclear waste drum inspection  £0.4m FlatScan por

  12. Slide 12: Current Trading

    Current Trading • Order base supporting H1 revenue • Margin diminished due to: – Increased market competition – Non-recurring engineering costs of new products introduced EOD screening • Increase R&D expenditure to support new products • Positive trading anticipated to continue through H1 • The chal

  13. Slide 13: In Summary

    In Summary • Company evolving into a proactive sales and marketing-led organisation • Focusing on wider range of standard products and more diffuse customer base • Range and value of contracts secured give tangible measure of success • Break-even position in the second half of 2011and positive tradi

  14. Slide 14: Important Notice

    Important Notice • This document is issued and approved for distribution within the United Kingdom by Image Scan Holdings plc (the “Company”) only to eligible counterparties and professional clients as defined in the FSA rules. It is not directed at, may not be suitable for and should not be relied

Image Scan Holdings — Shareholder Meeting (February 2012) on 6ix